Cadmium Evaluations Selection for surveillance: All individuals exposed above the Action Level for 30 or more days per year, previous exposure above the Action Level for a total of 60 months. Pre-placement: Medical and work history (cadmium exposure history, review of systems, smoking history). Physical examination with attention to the respiratory, renal, and skeletal systems. Biological monitoring (CdU, CdB, and 2-M) may be performed. Assignment to a surveillance category based on initial and subsequent biomonitoring results. Category A Category B Category C Medical examinations every Medical examinations at 90 Medical examinations at 90 other year. days, at 1 year, and then days, 6 months, and then every year. every 6 months. Laboratory examinations Laboratory examinations at 90 Laboratory examinations at 90 (CdU, CdB, every year. days, 6 months, and then days, 3 months, and then β2-M) every 6 months. every 3 months. CdU >3 and µg/g Creatinine >7 µg/g Creatinine ≤3 µg/g Creatinine ≤7 >5 and µg/liters whole ≤10 >10 µg/liters whole blood ≤5 µg/liters whole blood CdB blood µg/g Creatinine >300 and µg/g Creatinine >750 µg/g Creatinine β2-M ≤300 ≤750 Periodic: Medical and occupational history; physical examination including blood pressure with attention to the respiratory system, and the urinary system; chest x-ray if deemed clinically appropriate; spirometry; blood and urine biomonitoring of cadmium exposure; prostate exam for males over 40 years old Frequency: Per exposure category. Termination: Required if more than six months since last periodic examination: Medical history; physical examination; chest x-ray. Post-exposure emergency: Medical evaluation equivalent to periodic examination. Additional requirements: The OSHA cadmium standard includes provisions for medical removal based on biomonitoring results or clinical concern about exposure. References DOD 6055.05M, Table C2.T6; 29 CFR 1910.1027 Notes The cadmium standard is exacting and medical examiners should be familiar with its requirements.
Cadmium Evaluations Selection for surveillance: All individuals exposed above the Action Level for 30 or more days per year, previous exposure above the Action Level for a total of 60 months. Pre-placement: Medical and work history (cadmium exposure history, review of systems, smoking history). Physical examination with attention to the respiratory, renal, and skeletal systems. Biological monitoring (CdU, CdB, and 2-M) may be performed. Assignment to a surveillance category based on initial and subsequent biomonitoring results. Category A Category B Category C Medical examinations every other year. Medical examinations at 90 days, at 1 year, and then every year. Medical examinations at 90 days, 6 months, and then every 6 months. Laboratory examinations (CdU, CdB, β2-M) every year. Laboratory examinations at 90 days, 6 months, and then every 6 months. Laboratory examinations at 90 days, 3 months, and then every 3 months. CdU ≤3 µg/g Creatinine >3 and ≤7 µg/g Creatinine >7 µg/g Creatinine CdB ≤5 µg/liters whole blood >5 and ≤10 µg/liters whole blood >10 µg/liters whole blood β2-M ≤300 µg/g Creatinine >300 and ≤750 µg/g Creatinine >750 µg/g Creatinine Periodic: Medical and occupational history; physical examination including blood pressure with attention to the respiratory system, and the urinary system; chest x-ray if deemed clinically appropriate; spirometry; blood and urine biomonitoring of cadmium exposure; prostate exam for males over 40 years old Frequency: Per exposure category. Termination: Required if more than six months since last periodic examination: Medical history; physical examination; chest x-ray. Post-exposure emergency: Medical evaluation equivalent to periodic examination. Additional requirements: The OSHA cadmium standard includes provisions for medical removal based on biomonitoring results or clinical concern about exposure. References DOD 6055.05M, Table C2.T6; 29 CFR 1910.1027 Notes The cadmium standard is exacting and medical examiners should be familiar with its requirements.